Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Combination of Low White Blood Cell Count and Impaired Renal Function Is a Risk Factor for Higher Concentrations of Venetoclax and Prolonged Neutropenia in AML Patients with Venetoclax Combined Regimen: Real World Experience in the Japanese Cohort

Minoru Kanaya, Yuji Mukai, Mirei Kobayashi, Sayaka Kajikawa, Toma Suzuki, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Masanobu Morioka, Akio Mori, Toshihiro Matsukawa, Masahiro Onozawa, Goichi Yoshimoto, Mitsuru Moriyama, Sunggi Chi, Takanori Teshima, Yosuke Minami, Masato Honmma, Takeshi Kondo

Blood (2024) 144 (Supplement 1): 2930.

https://doi.org/10.1182/blood-2024-198943

Published: 2024

Journal Articles

Evaluation of Venetoclax Duration in Venetoclax-Azacitidine Regimen for Untreated Acute Myeloid Leukemia: Real World Experience from Hokkaido Leukemia Net

Blood (2024) 144 (Supplement 1): 6063.

https://doi.org/10.1182/blood-2024-200013

Published: 2024

Journal Articles

Evaluation of Lymphocyte Immunity in Patients Treated with Venetoclax-Azacitidine for Acute Myeloid Leukemia

Minoru Kanaya, Toma Suzuki, Sayaka Kajikawa, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Masanobu Morioka, Akio Mori, Toshihiro Matsukawa, Masahiro Onozawa, Takanori Teshima, Takeshi Kondo

Blood (2024) 144 (Supplement 1): 6061.

https://doi.org/10.1182/blood-2024-198084

Published: 2024

Journal Articles

The HLA-B Leader MM Genotype Has a Negative Impact on Outcomes in HLA-B One Antigen Mismatched and HLA-B Matched Cord Blood Transplantation without Anti-Thymocyte Globulin: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Blood (2023) 142 (Supplement 1): 1048.

https://doi.org/10.1182/blood-2023-178905

Published: 2023

Journal Articles

HLA Class I Genotypes Predict the Survival after Hematopoietic Stem Cell Transplantation in Immune Aplastic Anemia

Yoshitaka Zaimoku, Hirohito Yamazaki, Minoru Kanaya, Nobuhiro Hiramoto, Ken Ishiyama, Naoyuki Uchida, Noriko Doki, Ryusuke Yamamoto, Tetsuya Nishida, Koichi Onodera, Shinichiro Machida, Yoshinobu Kanda, Tetsuya Eto, Fumihiko Ishimaru, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta, Yasushi Onishi

Blood (2023) 142 (Supplement 1): 706.

https://doi.org/10.1182/blood-2023-191332

Published: 2023

Journal Articles

Affibody-Based BCMA x CD16 Dual Engagers for Activation of NK Cells Towards Multiple Myeloma

Kim Anh Giang, Mizuha Kanaya, Thorstein Boxaspen, Minoru Kanaya, Silje Zandstra Krokeide, Yumei Diao, Fredrik Schjesvold, Fredrik Lehmann, Johan Nilvebrant, Stefan Svensson Gelius, Karl-Johan Malmberg, Per-Åke Nygren

Blood (2022) 140 (Supplement 1): 10699–10700.

https://doi.org/10.1182/blood-2022-164753

Published: 2022

Journal Articles

Perturbed NK-cell homeostasis associated with disease severity in chronic neutropenia

Ebba Sohlberg, Aline Pfefferle, Eivind Heggernes Ask, Astrid Tschan-Plessl, Benedikt Jacobs, Herman Netskar, Susanne Lorenz, Minoru Kanaya, Mizuha Kosugi-Kanaya, Stephan Meinke, Anette Mörtberg, Petter Höglund, Mikael Sundin, Göran Carlsson, Jan Palmblad, Karl-Johan Malmberg

Blood (2022) 139 (5): 704–716.

https://doi.org/10.1182/blood.2021013233

Published: 2022

Includes: Supplemental data

Journal Articles

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Minoru Kanaya, Yasuo Morishima, Nobuyoshi Arima, Masahiro Hirayama, Souichi Shiratori, Noriko Doki, Yukiyasu Ozawa, Takahiro Fukuda, Masatsugu Tanaka, Masashi Sawa, Satoru Takada, Shuichi Ota, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima

Blood (2021) 138 (Supplement 1): 2919.

https://doi.org/10.1182/blood-2021-144669

Published: 2021

Journal Articles

CAR19 iPSC-Derived NK Cells Utilize the Innate Functional Potential Mediated through NKG2A-Driven Education and Override the HLA-E Check Point to Effectively Target B Cell Lymphoma

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-138527

Published: 2020

Journal Articles

Serum Soluble Interleukin-2 Receptor As a Surrogate Biomarker of Metabolic Tumor Volume Measured By 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma

Hajime Senjo, MD, Minoru Kanaya, MDPhD, Koh Izumiyama, MDPhD, Koichiro Minauchi, MD, Kenji Hirata, MDPhD, Akio Mori, Makoto Saito, Masanori Tanaka, Hiroaki Iijima, Eriko Tsukamoto, Kazuo Itoh, Shuichi Ota, MD, Masanobu Morioka, Daigo Hashimoto, MD, PhD, Takanori Teshima

Blood (2018) 132 (Supplement 1): 345.

https://doi.org/10.1182/blood-2018-99-111076

Published: 2018

Journal Articles

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Masahiro Ogasawara, MD, Ph.D, Tomohiro Yamakawa, MD, Yuki Katsura, MD, Kanako Shima, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Koichiro Minauchi, MD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Naoki Kobayashi, MD, Ph.D, Yoshio Kiyama, MD, Naoto Hirano, MD, Ph.D

Blood (2010) 116 (21): 2101.

https://doi.org/10.1182/blood.V116.21.2101.2101

Published: 2010

Journal Articles

Pre-Treatment Serum Soluble Interleukin-2 Receptor Value Significantly Predicts Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Shinsuke Noguchi, MD, Masanobu Nakata, MD, Kanako Shima, MD, Yuki Katsura, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Satomi Matsuoka, MD, Mizuha Kosugi, MD, Shiro Fujii, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Masahiro Ogasawara, MD, PhD, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD

Blood (2009) 114 (22): 3948.

https://doi.org/10.1182/blood.V114.22.3948.3948

Published: 2009

Journal Articles

Imatinib Mesylate Impairs the Function of Human Regulatory T Cells (Tregs) and Reverses the Inhibition of Immune Responses to Imatinib-Resistant CML Cells by Tregs.

Masahiro Ogasawara, Toshihiro Matsukawa, Yuki Katsura, Kanako Shima, Minoru Kanaya, Mizuha Kosugi, Satomi Matsuoka, Shiro Fujii, Shinsuke Noguchi, Shuichi Ota, MD, PhD, Masanobu Nakata, MD, Kiyotoshi Imai, Teiichi Hirano, Naoki Kobayashi, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD

Blood (2009) 114 (22): 4728.

https://doi.org/10.1182/blood.V114.22.4728.4728

Published: 2009

NARROW

Combination of Low White Blood Cell Count and Impaired Renal Function Is a Risk Factor for Higher Concentrations of Venetoclax and Prolonged Neutropenia in AML Patients with Venetoclax Combined Regimen: Real World Experience in the Japanese Cohort

Evaluation of Venetoclax Duration in Venetoclax-Azacitidine Regimen for Untreated Acute Myeloid Leukemia: Real World Experience from Hokkaido Leukemia Net

Evaluation of Lymphocyte Immunity in Patients Treated with Venetoclax-Azacitidine for Acute Myeloid Leukemia

The HLA-B Leader MM Genotype Has a Negative Impact on Outcomes in HLA-B One Antigen Mismatched and HLA-B Matched Cord Blood Transplantation without Anti-Thymocyte Globulin: Analysis of the Japanese Society for Transplantation and Cellular Therapy

HLA Class I Genotypes Predict the Survival after Hematopoietic Stem Cell Transplantation in Immune Aplastic Anemia

Affibody-Based BCMA x CD16 Dual Engagers for Activation of NK Cells Towards Multiple Myeloma

Perturbed NK-cell homeostasis associated with disease severity in chronic neutropenia

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

CAR19 iPSC-Derived NK Cells Utilize the Innate Functional Potential Mediated through NKG2A-Driven Education and Override the HLA-E Check Point to Effectively Target B Cell Lymphoma

Serum Soluble Interleukin-2 Receptor As a Surrogate Biomarker of Metabolic Tumor Volume Measured By 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Pre-Treatment Serum Soluble Interleukin-2 Receptor Value Significantly Predicts Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Imatinib Mesylate Impairs the Function of Human Regulatory T Cells (Tregs) and Reverses the Inhibition of Immune Responses to Imatinib-Resistant CML Cells by Tregs.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only